These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 24552184)
1. IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: rationale and protocol for an ongoing randomized controlled trial. Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Trials; 2014 Feb; 15():63. PubMed ID: 24552184 [TBL] [Abstract][Full Text] [Related]
2. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. Zeller T; Micari A; Scheinert D; Baumgartner I; Bosiers M; Vermassen FEG; Banyai M; Shishehbor MH; Wang H; Brodmann M; JACC Cardiovasc Interv; 2020 Feb; 13(4):431-443. PubMed ID: 32081236 [TBL] [Abstract][Full Text] [Related]
3. Paclitaxel-Coated Balloon in Infrapopliteal Arteries: 12-Month Results From the BIOLUX P-II Randomized Trial (BIOTRONIK'S-First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularization of infrapopliteal arteries). Zeller T; Beschorner U; Pilger E; Bosiers M; Deloose K; Peeters P; Scheinert D; Schulte KL; Rastan A; Brodmann M JACC Cardiovasc Interv; 2015 Oct; 8(12):1614-22. PubMed ID: 26493253 [TBL] [Abstract][Full Text] [Related]
4. Drug-eluting balloon versus standard balloon angioplasty for infrapopliteal arterial revascularization in critical limb ischemia: 12-month results from the IN.PACT DEEP randomized trial. Zeller T; Baumgartner I; Scheinert D; Brodmann M; Bosiers M; Micari A; Peeters P; Vermassen F; Landini M; Snead DB; Kent KC; Rocha-Singh KJ; J Am Coll Cardiol; 2014 Oct; 64(15):1568-76. PubMed ID: 25301459 [TBL] [Abstract][Full Text] [Related]
5. Outcomes After Drug-Coated Balloon Treatment of Femoropopliteal Lesions in Patients With Critical Limb Ischemia: A Post Hoc Analysis From the IN.PACT Global Study. Reijnen MMPJ; van Wijck I; Zeller T; Micari A; Veroux P; Keirse K; Lee SW; Li P; Voulgaraki D; Holewijn S J Endovasc Ther; 2019 Jun; 26(3):305-315. PubMed ID: 30931726 [TBL] [Abstract][Full Text] [Related]
6. Long-Term Clinical Effectiveness of a Drug-Coated Balloon for the Treatment of Femoropopliteal Lesions. Laird JA; Schneider PA; Jaff MR; Brodmann M; Zeller T; Metzger DC; Krishnan P; Scheinert D; Micari A; Wang H; Masters M; Tepe G Circ Cardiovasc Interv; 2019 Jun; 12(6):e007702. PubMed ID: 31195825 [TBL] [Abstract][Full Text] [Related]
7. Amputation-free Survival in Patients with Critical Limb Ischemia Treated with Paclitaxel-eluting Stents and Paclitaxel-coated Balloons. Phair J; Carnevale M; Lipsitz EC; Shariff S; Scher L; Garg K Ann Vasc Surg; 2020 Jan; 62():8-14. PubMed ID: 31207400 [TBL] [Abstract][Full Text] [Related]
8. Long-Term Follow-up of the PADI Trial: Percutaneous Transluminal Angioplasty Versus Drug-Eluting Stents for Infrapopliteal Lesions in Critical Limb Ischemia. Spreen MI; Martens JM; Knippenberg B; van Dijk LC; de Vries JPM; Vos JA; de Borst GJ; Vonken EPA; Bijlstra OD; Wever JJ; Statius van Eps RG; Mali WPTM; van Overhagen H J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411244 [TBL] [Abstract][Full Text] [Related]
9. Major adverse limb events and wound healing following infrapopliteal artery stent implantation in patients with critical limb ischemia: the XCELL trial. Rocha-Singh KJ; Jaff M; Joye J; Laird J; Ansel G; Schneider P; Catheter Cardiovasc Interv; 2012 Nov; 80(6):1042-51. PubMed ID: 22605682 [TBL] [Abstract][Full Text] [Related]
10. Drug-coated balloon angioplasty for the management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia. Palena LM; Diaz-Sandoval LJ; Gomez-Jaballera E; Peypoch-Perez O; Sultato E; Brigato C; Brocco E; Manzi M Cardiovasc Revasc Med; 2018; 19(1 Pt B):83-87. PubMed ID: 28648324 [TBL] [Abstract][Full Text] [Related]
11. Treatment Effect of Drug-Coated Balloons Is Durable to 3 Years in the Femoropopliteal Arteries: Long-Term Results of the IN.PACT SFA Randomized Trial. Schneider PA; Laird JR; Tepe G; Brodmann M; Zeller T; Scheinert D; Metzger C; Micari A; Sachar R; Jaff MR; Wang H; Hasenbank MS; Krishnan P; Circ Cardiovasc Interv; 2018 Jan; 11(1):e005891. PubMed ID: 29326153 [TBL] [Abstract][Full Text] [Related]
12. The "DEBELLUM"--lower limb multilevel treatment with drug eluting balloon--randomized trial: 1-year results. Fanelli F; Cannavale A; Corona M; Lucatelli P; Wlderk A; Salvatori FM J Cardiovasc Surg (Torino); 2014 Apr; 55(2):207-16. PubMed ID: 24670828 [TBL] [Abstract][Full Text] [Related]
13. Drug-eluting balloon in peripheral intervention for the superficial femoral artery: the DEBATE-SFA randomized trial (drug eluting balloon in peripheral intervention for the superficial femoral artery). Liistro F; Grotti S; Porto I; Angioli P; Ricci L; Ducci K; Falsini G; Ventoruzzo G; Turini F; Bellandi G; Bolognese L JACC Cardiovasc Interv; 2013 Dec; 6(12):1295-302. PubMed ID: 24239203 [TBL] [Abstract][Full Text] [Related]
14. IN.PACT SFA Clinical Study Using the IN.PACT Admiral Drug-Coated Balloon in a Chinese Patient Population. Chen Z; Guo W; Jiang W; Wang F; Fu W; Zou Y; Deckers S; Li P; Popma JJ; Jaff MR J Endovasc Ther; 2019 Aug; 26(4):471-478. PubMed ID: 31204595 [No Abstract] [Full Text] [Related]
15. BAlloon versus Stenting in severe Ischaemia of the Leg-3 (BASIL-3): study protocol for a randomised controlled trial. Hunt BD; Popplewell MA; Davies H; Meecham L; Jarrett H; Bate G; Grant M; Patel S; Hewitt C; Andronis L; Deeks JJ; Bradbury A; Trials; 2017 May; 18(1):224. PubMed ID: 28526046 [TBL] [Abstract][Full Text] [Related]
16. Drug-coated balloon versus uncoated percutaneous transluminal angioplasty for the treatment of atherosclerotic lesions in the superficial femoral and proximal popliteal artery: 2-year results of the MDT-2113 SFA Japan randomized trial. Iida O; Soga Y; Urasawa K; Saito S; Jaff MR; Wang H; Ookubo H; Yokoi H; Catheter Cardiovasc Interv; 2019 Mar; 93(4):664-672. PubMed ID: 30747489 [TBL] [Abstract][Full Text] [Related]
17. Paclitaxel-Eluting Balloon Versus Standard Balloon Angioplasty in In-Stent Restenosis of the Superficial Femoral and Proximal Popliteal Artery: 1-Year Results of the PACUBA Trial. Kinstner CM; Lammer J; Willfort-Ehringer A; Matzek W; Gschwandtner M; Javor D; Funovics M; Schoder M; Koppensteiner R; Loewe C; Ristl R; Wolf F JACC Cardiovasc Interv; 2016 Jul; 9(13):1386-92. PubMed ID: 27388828 [TBL] [Abstract][Full Text] [Related]
18. Drug-Coated Balloon Treatment of Femoropopliteal Lesions for Patients With Intermittent Claudication and Ischemic Rest Pain: 2-Year Results From the IN.PACT Global Study. Micari A; Brodmann M; Keirse K; Peeters P; Tepe G; Frost M; Wang H; Zeller T; JACC Cardiovasc Interv; 2018 May; 11(10):945-953. PubMed ID: 29798770 [TBL] [Abstract][Full Text] [Related]
19. Paclitaxel-coated balloon angioplasty versus drug-eluting stenting for the treatment of infrapopliteal long-segment arterial occlusive disease: the IDEAS randomized controlled trial. Siablis D; Kitrou PM; Spiliopoulos S; Katsanos K; Karnabatidis D JACC Cardiovasc Interv; 2014 Sep; 7(9):1048-56. PubMed ID: 25234679 [TBL] [Abstract][Full Text] [Related]
20. Drug-Coated Balloon Angioplasty in Clinical Practice for Below-the-Knee, Popliteal, and Crural Artery Lesions Causing Critical Limb Ischemia: 1-Year Results from the Spanish Luminor Registry. Riambau V; Acín F; de Blas MJ; Alonso M; Giménez-Gaibar A; Ann Vasc Surg; 2020 Jan; 62():387-396. PubMed ID: 31449955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]